Lytix Biopharma AS (OSL:LYTIX)

Lytix Biopharma AS Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 2, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	334	401	195	311	533	-
Market Cap Growth	106.12%	106.12%	-37.37%	-41.63%	-	-
Enterprise Value	206	361	116	139	323	-
Last Close Price	4.89	5.88	4.86	7.76	13.75	-
PS Ratio	23.78	36.05	48.79	28.19	27.59	-
PB Ratio	3.09	3.72	3.80	2.30	2.81	-
P/TBV Ratio	3.72	3.72	3.80	2.30	2.81	-
EV/Sales Ratio	18.47	32.39	29.06	12.63	16.76	-
Debt / Equity Ratio	0.02	0.02	0.01	0.01	0.01	-
Asset Turnover	0.11	0.11	0.04	0.06	0.16	0.16
Quick Ratio	3.91	3.91	5.01	8.51	14.29	2.52
Current Ratio	3.91	3.91	5.06	8.55	14.33	2.56
Return on Equity (ROE)	-118.41%	-118.41%	-94.33%	-34.54%	-45.90%	-251.50%
Return on Assets (ROA)	-56.97%	-56.97%	-55.72%	-22.90%	-25.23%	-105.82%
Return on Capital (ROIC)	-73.84%	-73.84%	-64.29%	-25.01%	-28.34%	-158.25%
Earnings Yield	-28.24%	-23.48%	-45.14%	-18.03%	-9.03%	-
FCF Yield	-17.53%	-17.53%	-49.17%	-16.98%	-8.37%	-
Buyback Yield / Dilution	-35.10%	-35.10%	-1.01%	-19.50%	-26.57%	-14.56%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.